[Federal Register Volume 83, Number 26 (Wednesday, February 7, 2018)]
[Notices]
[Page 5465]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-02375]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes; Meeting 
Notice

AGENCY: Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

    The U.S. Nuclear Regulatory Commission will convene a meeting of 
the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on March 
7-8, 2018. A sample of agenda items to be discussed during the public 
session includes: (1) A discussion on medical-related events; (2) an 
update on the worldwide supply and domestic production of molybdenum-
99; (3) a discussion on the resources needed to address the development 
of emerging medical technologies; and (4) a discussion of staff's 
evaluation of the ACMUI's recommendations related to medical event 
reporting under title 10 Code of Federal Regulations (10 CFR) 35.3045 
and impact on safety culture at medical institutions. The agenda is 
subject to change. The current agenda and any updates will be available 
at http://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2018.html or by emailing Ms. Sophie Holiday at the contact information 
below.
    Purpose: Discuss issues related to 10 CFR part 35 Medical Use of 
Byproduct Material.
    Date and Time for Open Sessions: March 7, 2018, from 8:30 a.m. to 
2:30 p.m. and March 8, 2018, from 8:30 a.m. to 2:45 p.m. Eastern 
Standard Time.
    Address for Public Meeting: U.S. Nuclear Regulatory Commission, Two 
White Flint North Building, Room T2-B3, 11545 Rockville Pike, 
Rockville, Maryland 20852.
    Public Participation: Any member of the public who wishes to 
participate in the meeting in person or via phone should contact Ms. 
Holiday using the information below. The meeting will also be webcast 
live at https://video.nrc.gov/.
    Contact Information: Sophie Holiday, email: [email protected], 
telephone: (301) 415-7865.

Conduct of the Meeting

    Philip O. Alderson, M.D. will chair the meeting. Dr. Alderson will 
conduct the meeting in a manner that will facilitate the orderly 
conduct of business. The following procedures apply to public 
participation in the meeting:
    1. Persons who wish to provide a written statement should submit an 
electronic copy to Ms. Holiday using the contact information listed 
above. All submittals must be received by March 2, 2018, three business 
days before the meeting, and must pertain to the topics on the agenda 
for the meeting.
    2. Questions and comments from members of the public will be 
permitted during the meeting, at the discretion of the Chairman.
    3. The draft transcript and meeting summary will be available on 
ACMUI's website http://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2018.html on or about April 19, 2018.
    4. Persons who require special services, such as those for the 
hearing impaired, should notify Ms. Holiday of their planned 
attendance.
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in 10 
CFR part 7.

    Dated at Rockville, Maryland this 1st day of February, 2018.

    For the Nuclear Regulatory Commission.
Russell E. Chazell,
Advisory Committee Management Officer.
[FR Doc. 2018-02375 Filed 2-6-18; 8:45 am]
 BILLING CODE 7590-01-P